RecruitingPhase 2NCT05806931
Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer
Sponsor: Rutgers, The State University of New Jersey
Elizabeth, NJ · Jersey City, NJ · Lakewood, NJ · +6 more sites
Colorectal Cancer clinical trials in Jersey City, NJ
2 recruiting colorectal cancer studies with a site in Jersey City, NJ.
All trials in Jersey City, NJ · All Colorectal Cancer trials
RecruitingPhase 4NCT07158164
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
Sponsor: Rutgers, The State University of New Jersey
Belleville, NJ · Elizabeth, NJ · Hamilton, NJ · +9 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.